Skip to main content

You will need to login before you can apply for a job.

Senior Scientist, RNA Technologies

Intellia Therapeutics
Cambridge, MA
Start date
Jun 17, 2024

View more

Science/R&D, Biotechnology
Required Education
Masters Degree/MBA
Position Type
Full time
Genetown, Best Places to Work

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

As a Senior Scientist, you will join our RNA Technologies team within the Chemistry and Delivery Sciences group and embrace the opportunity to transform amazing sciences and technologies into powerful cures. You will be responsible for providing support inRNA platform development by leading mRNA discovery and implementing new and existing mRNA process and leading guide RNA design and modification.

Main responsibilities also include:

  • Functions independently as a technical expert in mRNA synthesis by enzymatic method development, execution, and troubleshooting.

  • Evaluates novel RNA technologies and methodologies that could improve our RNA quality.

  • Design and modify guide RNA that could improve guide RNA stability and potency.

  • Provides leadership in collaboration with colleagues across disciplines from early research to process teams in support of project goals and timelines.

  • Coordinate product characterization and in-process testing of mRNA molecules.

About you:

Your experience working with RNA and your understanding of the basic principles and CRISPR (gene editing) techniques necessary to characterize RNA quality and function will enable you to be successful. Most importantly, if you have an enthusiastic curiosity to develop RNA processes and learn about the future of medicine in gene editing, we strongly encourage you to apply! Other qualifications and desired skills include:

  • PhD in Biochemistry, Molecular Biology or related area with 3~ 5 years of post-PhD relevant experience or Master’s degree with 8 ~10 years of relevant experience

  • Previous experience with RNA Biochemistry and/or CRISPR/Gene Editing Techniques is a must

  • RNA and oligos development experience utilizing bioanalytical tools such as (U/HPLC, FPLC, CE, gel electrophoresis, and sequencing) is desirable

  • Experience managing people is a plus

  • Organized, detail-oriented, and demonstrated independent thinker who continuously seeks innovative solutions

  • Excellent verbal and written communication,teamwork, and strong problem-solvingskills

Meet your future team:

The RNA Technologies team is a fun, brilliant and energetic team of scientists focused on the RNA platform development to create the curative gene-editing technologies of the future. This group is responsible for driving the early-stage development of Intellia’s RNA DS for Intellia’s lead programs. Furthermore, we are responsible for the development of enzymatic process and characterization tools to build a wide range of mRNA modalities for Intellia’s next-generation platform technologies. Additionally, we are responsible to design and modify guide RNA to increase its stability/potency for new pipeline application.

You will report to the Director, RNA Technologies. He is leading to advance our RNA gene therapy platforms and participate in developing innovative therapies for patients. He loves to see people grow and develop and look forward to learning from your experiences and building the team together with you.


Covid-19 Vaccination Policy:All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.


Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA


Company info
(857) 285-6200
40 Erie Street

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert

Similar jobs